Correction to: Investigation of perfusion defects by Q‑SPECT/CT in patients with mild‑to‑moderate course of COVID‑19 and low clinical probability for pulmonary embolism

Abstract

In the original publication of the article, the corresponding author was wrongly assigned as "Sermin Borekci" instead of "Buket Caliskaner Ozturk".The publisher sincerely apologizes for any inconvenience this error may have caused.Publisher's Note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Investigation of the ongoing pulmonary defects with perfusion-single photon emission computed tomography/computed tomography in patients under anticoagulant therapy for coronavirus disease 2019–induced pulmonary embolism

“…In a study comparing V/Q scintigraphy, V/Q-SPECT, and V/Q-SPECT/computed tomography (V/Q-SPECT/CT), the sensitivity and specificity of V/Q-SPECT/CT were found to be significantly higher than the others [5]. In PE due to COVID-19, as the pathology originates from more distal to the segmental arteries due to microvascular damage, the effective role of V/Q-SPECT/CT and perfusion-SPECT/CT (Q-SPECT/CT) has been shown in the diagnosis of these patients [6,7].…”